JP2011516041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516041A5 JP2011516041A5 JP2010550830A JP2010550830A JP2011516041A5 JP 2011516041 A5 JP2011516041 A5 JP 2011516041A5 JP 2010550830 A JP2010550830 A JP 2010550830A JP 2010550830 A JP2010550830 A JP 2010550830A JP 2011516041 A5 JP2011516041 A5 JP 2011516041A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibodies
- seq
- tyrp1
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6919908P | 2008-03-12 | 2008-03-12 | |
| US61/069,199 | 2008-03-12 | ||
| PCT/US2009/036739 WO2009114585A1 (en) | 2008-03-12 | 2009-03-11 | Anti-tyrp1 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011516041A JP2011516041A (ja) | 2011-05-26 |
| JP2011516041A5 true JP2011516041A5 (enExample) | 2014-03-06 |
Family
ID=40790741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010550830A Pending JP2011516041A (ja) | 2008-03-12 | 2009-03-11 | 抗ｔｙｒｐ１抗体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7951370B2 (enExample) |
| EP (1) | EP2268672A1 (enExample) |
| JP (1) | JP2011516041A (enExample) |
| KR (1) | KR101203777B1 (enExample) |
| CN (1) | CN101970500B (enExample) |
| AR (1) | AR070821A1 (enExample) |
| AU (1) | AU2009222998B2 (enExample) |
| BR (1) | BRPI0909633A2 (enExample) |
| CA (1) | CA2718289A1 (enExample) |
| CL (1) | CL2009000567A1 (enExample) |
| EA (1) | EA019517B1 (enExample) |
| IL (1) | IL207581A0 (enExample) |
| MX (1) | MX2010010021A (enExample) |
| NZ (1) | NZ587305A (enExample) |
| PE (1) | PE20091679A1 (enExample) |
| TW (1) | TWI384997B (enExample) |
| UA (1) | UA99339C2 (enExample) |
| WO (1) | WO2009114585A1 (enExample) |
| ZA (1) | ZA201006099B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101163295B1 (ko) * | 2007-06-29 | 2012-07-05 | 에프. 호프만-라 로슈 아게 | 향상된 면역글로불린을 생산하는 중쇄 돌연변이체 |
| JP6464436B2 (ja) | 2014-02-07 | 2019-02-06 | アジュ ユニバーシティー インダストリー−アカデミック コーオペレイション ファウンデーションＡｊｏｕ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎｄｕｓｔｒｙ−Ａｃａｄｅｍｉｃ Ｃｏｏｐｅｒａｔｉｏｎ Ｆｏｕｎｄａｔｉｏｎ | 受容体共役タンパク質キナーゼ−３（ｒｉｐ３）発現促進剤を有効成分として含む抗癌補助用組成物、受容体共役タンパク質キナーゼ−３（ｒｉｐ３）の発現を促して抗癌剤感受性を増進させる抗癌補助剤のスクリーニング方法及び抗癌剤感受性のモニターリング方法 |
| EP3233907B1 (en) | 2014-12-19 | 2021-03-03 | Genmab A/S | Rodent bispecific heterodimeric proteins |
| RU2630647C1 (ru) * | 2016-05-27 | 2017-09-11 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО К КОНФОРМАЦИОННОМУ ЭПИТОПУ С3 КОМПОНЕНТА КОМПЛЕМЕНТА ЧЕЛОВЕКА, ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК (ВАРИАНТЫ), ЭКСПРЕССИОННЫЙ ВЕКТОР, СОДЕРЖАЩИЙ ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК (ВАРИАНТЫ), И ШТАММ КЛЕТОК ЯИЧНИКОВ КИТАЙСКОГО ХОМЯЧКА CHO-humC34-ПРОДУЦЕНТ ДАННОГО ГУМАНИЗИРОВАННОГО АНТИТЕЛА |
| GB201613167D0 (en) | 2016-07-29 | 2016-09-14 | Univ Southampton | Cancer and b-cell related disease therapy |
| WO2018075586A1 (en) * | 2016-10-18 | 2018-04-26 | Memorial Sloan-Kettering Cancer Center | Antigen-binding proteins targeting melanoma differentiation antigens and uses thereof |
| KR20200021074A (ko) * | 2017-06-14 | 2020-02-27 | 아디셋 바이오, 인크. | Hla 제한된 방식으로 hla-a2/tyrd를 결합할 수 있는 항체 및 이의 용도 |
| RU2687609C1 (ru) * | 2018-05-30 | 2019-05-15 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | Гуманизированное антитело к конформационному эпитопу сз компонента комплемента человека |
| SG11202102781UA (en) | 2018-09-27 | 2021-04-29 | Autolus Ltd | Chimeric antigen receptor |
| JP7440509B2 (ja) | 2018-11-09 | 2024-02-28 | ベス イスラエル デアコネス メディカル センター | Ｃｄｃｐ１－標的化療法 |
| SG11202102859TA (en) | 2018-12-21 | 2021-04-29 | Hoffmann La Roche | Antibodies binding to cd3 |
| US20230049954A1 (en) * | 2019-09-06 | 2023-02-16 | The Regents Of The University Of California | Chimeric antigen receptors and related methods and compositions for the treatment of cancer |
| EP4121454A1 (en) * | 2020-03-19 | 2023-01-25 | Imperial College Innovations Limited | Coronavirus antibody |
| CN118284625A (zh) * | 2021-11-26 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 抗tyrp1/抗cd3双特异性抗体与tyrp1特异性抗体的组合疗法 |
| AU2024381207A1 (en) | 2023-11-17 | 2026-05-14 | Institut National de la Santé et de la Recherche Médicale | Antineoplastic combinations |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4798790A (en) | 1985-07-18 | 1989-01-17 | Sloan-Kettering Institute | Monoclonal antibody specific for a pigmentation associated antigen |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JPH02500329A (ja) | 1987-05-21 | 1990-02-08 | クリエイテイブ・バイオマリキユールズ・インコーポレーテツド | ターゲット化多機能蛋白質 |
| IL89489A0 (en) | 1988-03-09 | 1989-09-10 | Hybritech Inc | Chimeric antibodies directed against human carcinoembryonic antigen |
| KR900700134A (ko) | 1988-04-15 | 1990-08-11 | 원본미기재 | Il-2 수용체-특이적 키메릭 항체 |
| ATE119198T1 (de) | 1988-04-16 | 1995-03-15 | Celltech Ltd | Verfahren zur herstellung von proteinen mittels rekombinanter dna. |
| IE20000918A1 (en) | 1990-03-22 | 2001-05-30 | Sloan Kettering Inst Cancer | GP75 As a Tumor Vaccine for Melanoma |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| AU4025193A (en) | 1992-04-08 | 1993-11-18 | Cetus Oncology Corporation | Humanized C-erbB-2 specific antibodies |
| AU6171196A (en) * | 1995-06-07 | 1996-12-30 | Sloan-Kettering Institute For Cancer Research | Therapeutic uses of ta99 |
| US5840839A (en) | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| WO1999025379A1 (en) * | 1997-11-14 | 1999-05-27 | Euro-Celtique, S.A. | Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| NZ522847A (en) * | 2000-05-16 | 2004-11-26 | Bolder Biotechnology Inc | Methods for refolding proteins containing free cysteine residues |
| EP1805320B1 (en) * | 2004-10-22 | 2014-09-03 | Amgen Inc. | Methods for refolding of recombinant antibodies |
-
2009
- 2009-03-11 UA UAA201010912A patent/UA99339C2/ru unknown
- 2009-03-11 MX MX2010010021A patent/MX2010010021A/es active IP Right Grant
- 2009-03-11 CN CN2009801085150A patent/CN101970500B/zh not_active Expired - Fee Related
- 2009-03-11 EA EA201071068A patent/EA019517B1/ru not_active IP Right Cessation
- 2009-03-11 BR BRPI0909633A patent/BRPI0909633A2/pt not_active IP Right Cessation
- 2009-03-11 US US12/401,800 patent/US7951370B2/en not_active Expired - Fee Related
- 2009-03-11 CA CA2718289A patent/CA2718289A1/en not_active Abandoned
- 2009-03-11 AR ARP090100858A patent/AR070821A1/es not_active Application Discontinuation
- 2009-03-11 WO PCT/US2009/036739 patent/WO2009114585A1/en not_active Ceased
- 2009-03-11 KR KR1020107020296A patent/KR101203777B1/ko not_active Expired - Fee Related
- 2009-03-11 TW TW098107909A patent/TWI384997B/zh not_active IP Right Cessation
- 2009-03-11 EP EP09719438A patent/EP2268672A1/en not_active Withdrawn
- 2009-03-11 CL CL2009000567A patent/CL2009000567A1/es unknown
- 2009-03-11 JP JP2010550830A patent/JP2011516041A/ja active Pending
- 2009-03-11 NZ NZ587305A patent/NZ587305A/en not_active IP Right Cessation
- 2009-03-11 AU AU2009222998A patent/AU2009222998B2/en not_active Ceased
- 2009-03-11 PE PE2009000356A patent/PE20091679A1/es not_active Application Discontinuation
-
2010
- 2010-08-12 IL IL207581A patent/IL207581A0/en unknown
- 2010-08-26 ZA ZA2010/06099A patent/ZA201006099B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3683239B1 (en) | Antibodies binding human claudin 18.2 and uses thereof | |
| TWI384997B (zh) | 抗酪胺酸酶相關蛋白-１（ｔｙｒｐ１）抗體 | |
| JP7575102B2 (ja) | Ｍｕｃ１８に特異的な抗体 | |
| CN105968206B (zh) | 抗erbb3抗体 | |
| JP2021531826A (ja) | 栄養膜細胞表面抗原２（ｔｒｏｐ２）に対する特異的な抗体 | |
| EP4166196A1 (en) | Antibodies binding cd24, preparation and use thereof | |
| CN108290948A (zh) | 抗-cd47抗体及使用方法 | |
| EP4292611A1 (en) | Anti-cd112r antibody and use thereof | |
| US20100092455A1 (en) | Novel anti-proliferation antibodies | |
| CN113474362A (zh) | 对cd44特异性的抗体 | |
| RU2754760C2 (ru) | Водная фармацевтическая композиция анти-il17a антитела и ее применение | |
| JP7578289B2 (ja) | Ｍｕｃ１８に特異的な抗体 | |
| KR102500845B1 (ko) | 항-tigit 항체 및 이의 용도 | |
| CN116262135B (zh) | 抗cd27抗体组合物及其用途 | |
| WO2020098672A1 (zh) | 一种融合蛋白及其用途 | |
| CN116262790A (zh) | 嵌合的抗cd27抗体组合物及其应用 | |
| WO2023093831A1 (zh) | 包含SIRPα突变体的融合蛋白 | |
| WO2023045859A1 (zh) | Cd38单克隆抗体及其应用 | |
| CN119584995A (zh) | 组合疗法 | |
| EP4549466A1 (en) | Development and use of novel multispecific tumor inhibitor | |
| HK40120136A (en) | Bispecific binding proteins against alarmins and uses thereof | |
| WO2025182946A1 (ja) | 肥満細胞が病態を増悪させる疾患の治療及び／又は予防用医薬組成物 | |
| KR20260013464A (ko) | 항-콜로니 자극 인자 1 수용체 항체를 이용한 만성 이식편대숙주 질환-관련 폐쇄성 세기관지염 증후군의 치료 방법 | |
| HK40089438A (zh) | 抗cldn-18.2抗体及其用途 | |
| HK40089438B (en) | Anti-cldn-18.2 antibody and use thereof |